4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-24-000141
Co-Chief Executive Officer acquired 44,052 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Co-Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-11 | Grant or award : show line 1 in the form | +44,052 | $22.70 | $999,980 | 24,967,852 | I |
Loading xslF345X05/wk-form4_1726270177.xml…